DHI Hair Transplant Patient Journey Timeline: Consultation to Final Results
A week-by-week guide to DHI hair transplant recovery, covering your Istanbul procedure from pre-departure preparation through 12-month results. Includes shock loss timeline, edema management, and remote follow-up planning.
Last reviewed: 2026-05-06
38 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
DHI recovery is typically 7–10 days for visible social improvement, shorter than standard FUE (10–14 days), though individual healing variation is significant
Postoperative edema peaks at day 4 and resolves by day 6–7 in most patients — head elevation 30–45° and cold compresses (not directly on grafts) are the primary management tools
Shock loss — temporary shedding of transplanted hairs — occurs in weeks 2–4 and is a normal, expected response, not a complication
Visible hair growth typically begins 2–3 months post-procedure; full cosmetic results are assessed at 12–18 months
Istanbul-based DHI patients should confirm a remote follow-up protocol with their clinic before booking flights — escalation planning is essential after departure
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Overview: What Is DHI and Why the Patient Journey Matters
DHI — Direct Hair Implantation — is a modified follicular unit extraction (FUE) technique that uses the Choi Implanter Pen to extract, sort, and implant follicular units in a single pass. Unlike standard FUE, which requires pre-made recipient-site incisions before implantation, the Choi implanter creates the puncture and deposits the graft simultaneously. This distinction has specific implications for your recovery timeline, graft handling, and postoperative care.
According to the International Society of Hair Restoration Surgery (ISHRS), DHI is classified as an implantation modification of the FUE method — not a separate hair transplant method. The technique was developed in South Korea and has been adapted internationally, including at high-volume Istanbul clinics. Understanding this distinction matters: the same evidence base governing FUE safety and outcomes applies to DHI, with some specific recovery differences documented in the literature.
A chronological patient journey timeline matters because hair transplant recovery is not linear. The first week looks very different from month three, and the months 2–4 "ugly duckling" phase is the period where patients most commonly misinterpret normal healing as failure. Knowing what to expect at each stage — and when variation is still within normal range — reduces unnecessary anxiety and prevents premature conclusions about your outcome.
If you are in the early research phase and have not yet chosen between techniques, our FUE vs DHI comparison covers the clinical and logistical differences in detail. You can also explore the broader Hair Transplant Resource Hub for an overview of all hair transplant options.
Pre-Departure: Preparing for DHI Surgery Abroad
The 2–4 weeks before your procedure are the most important window for outcome optimization and risk reduction. Most complications that arise during recovery can be traced back to pre-operative decisions — what medications were continued, how thoroughly the scalp was prepared, and how well the travel logistics were coordinated. Taking this phase seriously is one of the highest-value actions you can take as a patient.
Before you commit to a clinic, verify that the surgeon and facility meet minimum standards. Review our Hair Transplant Candidacy: Facility Audit guide for a checklist covering surgeon credentials, facility accreditation, and complication tracking. Our Hair Transplant Candidacy: Travel Logistics guide covers Istanbul-specific logistics in detail.
Medical Evaluation and Clearance
Before discontinuing any medication, discuss your plans with the prescribing physician. The following are general guidelines only — your surgeon will provide personalized instructions based on your medical history.
Blood thinners: do not stop without medical guidance
If you are on prescription anticoagulants such as warfarin, clopidogrel, or rivaroxaban, you must consult your prescribing physician before pausing any dose. Stopping these medications without supervision can carry serious risks. Your surgical team and prescribing physician should jointly develop a medication management plan in the weeks before your procedure.
Medications and Substances to Avoid
The following substances can increase bleeding risk, affect graft survival, or interfere with anesthesia. Clinical protocols vary slightly between clinics; always confirm the specific list your surgeon provides. Commonly accepted cessation timelines include:
Aspirin and other NSAIDs (ibuprofen, naproxen): stop 10 days before surgery — these inhibit platelet aggregation and can increase intraoperative and postoperative bleeding
Vitamin E and fish oil supplements: stop 3 weeks before surgery — these have anticoagulant properties
Alcohol: avoid for 48–72 hours before surgery as it can increase bleeding risk and interact with sedatives used during the procedure
Herbal supplements (gingko biloba, garlic extract, ginseng, St. John's Wort): many have documented or potential anticoagulant effects; disclose all supplements to your surgical team
Most clinics will request a routine blood work panel before clearance. This typically includes complete blood count, coagulation profile, and basic metabolic panel. Some clinics also screen for infectious diseases per standard surgical protocols.
Scalp and Hair Preparation
Most clinics request that you do not shave your hair before the procedure — the surgical team will handle shaving of the donor area on the day
Wash your hair with a non-medicated shampoo 1–2 days before surgery
Avoid topical minoxidil 3–5 days before the procedure (confirm with your surgeon, as protocols vary)
Avoid significant UV exposure or sunburn to the scalp for 2 weeks before surgery — damaged skin heals more slowly and is more prone to complications
Travel Logistics and Istanbul Clinic Coordination
Istanbul is one of the world's most active hair transplant tourism destinations, and most clinics serving international patients have logistics packages that include airport transfer, hotel accommodation, and in-country transportation. However, patients should verify exactly what is included and plan with the following in mind:
Recommended minimum stay in Istanbul: 4–5 nights. This accommodates the consultation day, the procedure day, and at least one post-operative follow-up appointment before departure. Some patients with larger sessions or slower healing may need 6–7 nights. Flight departure should be no earlier than day 3–4 post-operatively — confirm with your surgeon that you are cleared to fly before booking.
Packing tip: button-front shirts and a travel pillow
Bring 2–3 button-front or zip-front shirts — you will be wearing them for the first several days after the procedure. A U-shaped travel pillow is also highly recommended for sleeping with your head elevated at 30–45 degrees. These small practical details significantly reduce graft trauma risk and improve sleep quality during the critical first week.
Most Istanbul clinics offering medical tourism packages provide VIP airport transfer from either Istanbul Airport (IST) on the European side or Sabiha Gökçen Airport (SAW) on the Asian side. A driver will typically wait in the arrivals hall with a name card. Transfers are arranged in advance through the clinic's patient coordinator — confirm the WhatsApp contact details before you depart from home.
Transport goes either to the clinic directly (if the consultation is same-day as arrival) or to the hotel, depending on your scheduled appointment time. Most clinics recommend arriving at least one full day before the procedure to rest and acclimate.
Initial Consultation and Final Planning
The preoperative consultation is a critical safety step — it is where the surgeon assesses your donor capacity, confirms the recipient area, finalizes the hairline design, and ensures you are a suitable candidate. Per clinical guidelines, the surgeon should personally conduct this consultation and document the agreed-upon surgical plan.
During this consultation, you should expect:
A review of your medical history and any changes since your initial evaluation
A physical examination of the donor zone (typically the occipital and parietal scalp) to confirm graft availability
Hairline design discussion with your input — request to see a mirror and confirm the design before agreeing
Graft count estimation and discussion of realistic density goals
Review of the consent form, which should include documented risks, expected complications, and anticipated timeline for results
Request written postoperative instructions before you leave the consultation. You should also confirm the emergency contact number for post-operative concerns and understand the clinic's protocol for after-hours contact. Per ISHRS Core Curriculum, the surgeon is responsible for personally performing or directly supervising all critical steps of the procedure — confirm this will be the case before proceeding.
What to Pack for the Procedure Day
On procedure morning, arrive at the clinic in clean, loose clothing with button-front or zip-front shirts already arranged. Do not apply any hair products, makeup, or styling aids. If you have been prescribed a preoperative anxiolytic, take it as directed with a small sip of water.
Verify your payment arrangements and package inclusions (graft count, hotel nights, transfer details) with the coordinator the evening before.
Procedure Day: What to Expect
Arrival and Anesthesia
The DHI procedure begins with local anesthesia — specifically tumescent lidocaine — administered to both the donor zone (back and sides of the scalp) and the recipient area. Tumescent anesthesia involves a large volume of dilute anesthetic solution injected beneath the skin, which both numbs the area and reduces bleeding by compressing small blood vessels.
Per ISHRS post-treatment guidelines, oral premedication with anxiolytics may be offered for anxiety reduction during the longer procedure. Patients remain awake and conscious throughout, which is standard for hair transplant surgery. Some clinics offer light oral sedation in addition to local anesthesia. Pain during the procedure is generally reported as discomfort rather than acute pain — most patients describe it as comparable to a dental procedure.
Your selection of anesthetic and premedication protocol depends on your medical history, age, procedure duration, and surgeon preference. Inform the surgical team of any previous adverse reactions to local anesthetics.
The Extraction Phase
The surgeon or trained extraction technician (operating under direct physician supervision per ISHRS curriculum standards) harvests individual follicular units from the safe donor zone using a micro-punch, typically 0.7–1.0 mm in diameter for DHI. The safe donor zone is the region of the scalp — generally the occipital and parietal regions — where follicles are genetically resistant to dihydrotestosterone (DHT) and less likely to be lost to androgenetic alopecia.
Extracted grafts are sorted by hair count (1, 2, 3, or 4 hairs per follicular unit) and stored in a hypothermic preservation solution to maintain viability outside the body. The shorter the time between extraction and implantation, the better for graft survival — this is one of DHI's theoretical advantages, which we address in the DHI vs. FUE comparison section.
The 2013 Sethi study reported 93% good results in 29 DHI patients, though this is a relatively small series. Graft survival data from larger hair transplant literature — including StatPearls (2025) — indicates approximately 87% graft survival at 1 year in population averages, with significant methodological variation across studies.
The Implantation Phase (DHI Specific)
The defining feature of DHI is the use of the Choi Implanter Pen (also called a DHI implanter or hair implanter pen). The pen holds a single follicular unit in its needle, which is inserted to the correct angle and depth and then depressed to simultaneously create the recipient puncture and deposit the graft. No prior incision or channel creation is required at the recipient site.
This "stick-and-place" approach allows the surgeon to control implantation angle and depth in real time, which may offer advantages for hairline design and natural appearance. Per Avram et al. (2019), implantation angle and direction are among the most important determinants of aesthetic outcome in hair transplantation. The 2020 FDA clearance record documents the regulatory classification of DHI implanter devices as cleared medical instruments.
Duration and Immediate Post-Op
DHI procedures average approximately 437 minutes (about 7–8 hours) for a session of roughly 2,900 grafts, compared to approximately 373 minutes for an equivalent FUE session according to comparative analyses. The longer duration is due to the sequential extraction-sorting-implantation workflow. Larger sessions (>3,500–4,000 grafts) may take significantly longer and may not be practical with the DHI approach alone.
Immediately after the procedure, the surgeon or coordinator will:
Apply a protective dressing to the donor area (recipient area is typically left open)
Provide postoperative prescriptions: typically antibiotics (5–7 days), analgesics, and sometimes oral corticosteroids to reduce swelling
Give written postoperative instructions covering sleeping position, head-washing protocol, activity restrictions, and medication schedule
Confirm the emergency contact number for post-operative concerns — this should be active 24 hours for international patients
Most patients are discharged 2–4 hours after the procedure concludes. You should not drive after receiving oral premedication. Arrange for a companion or clinic-arranged transfer for the journey back to the hotel.
First night: head elevation is critical
Sleep with your head elevated at 30–45 degrees for the first 3–4 nights. This is one of the most important graft-protection measures — lying flat increases blood flow to the scalp and worsens frontal edema. Use a travel pillow to prevent accidentally rolling onto your side or front during sleep. Frontal swelling that extends into the eyes and upper face is common and usually peaks around day 4 before resolving.
The first 72 hours after your DHI procedure are the highest-risk window for graft dislodgement and early complication detection. Your primary job during this period is graft protection, pain management, and watching for signs that require immediate clinical contact.
Pain and Discomfort Management
Pain during days 1–3 is typically mild to moderate and responds well to prescribed analgesics or acetaminophen. According to ISHRS aftercare data, most patients describe the discomfort as tenderness rather than severe pain. If you experience pain that is not controlled by prescribed medication, contact the clinic — this is not normal and may indicate a developing complication.
Avoid NSAIDs such as ibuprofen and aspirin during the first week unless specifically approved by your surgeon, as these can increase bleeding risk at the graft sites.
Bleeding, Oozing, and Dressing Care
Minor seepage from recipient graft sites in the first few hours is normal and expected. Persistent or heavy bleeding — where blood soaks through dressings or drips actively — is not normal and requires immediate contact with the clinic. Per complication data from large series, bleeding requiring intervention occurs in up to 8% of cases, though it is less common in experienced hands.
The donor area may be bandaged; follow your clinic's specific instructions about when to remove or change any dressings. The recipient area should not have any pressure applied to it — no hats, headphones, or head coverings that press on the grafted zone until your surgeon clears this.
Sleep Position and Head Elevation
Sleep with your head elevated at 30–45 degrees using a travel pillow or by propping the head of the hotel bed mattress. This position reduces blood flow to the scalp, minimizes frontal edema, and protects grafts from friction against pillow surfaces. The risk of graft dislodgement is highest in the first 48 hours.
When to Call Your Clinic (Warning Signs)
Urgent signs requiring immediate clinic contact — or emergency care
Contact your clinic immediately (or seek emergency services) if you experience:
Heavy, persistent bleeding from the recipient area that does not stop with gentle pressure
Fever >38.5°C (101.3°F) or chills, especially if accompanied by spreading redness
Spreading redness with warmth and swelling beyond the immediate graft area
Pus or foul odor from graft sites — this may indicate infection
Sudden severe pain not responding to prescribed medication
Shortness of breath or chest pain — very rare but requires calling emergency services, not a clinic
Asymmetric or one-sided tense swelling — possible hematoma that may need drainage
Postoperative infection rates in modern hair transplant settings are documented at under 1% in experienced clinics, although some large series report up to 11% — the wide range reflects variation in study definitions and detection methods. True rates in high-volume, accredited settings are likely at the lower end of published ranges.
Your day 1 post-operative follow-up appointment at the clinic is standard practice — the surgeon checks graft stability and donor area healing. Do not skip this appointment, even if you feel fine. If you are cleared to depart Istanbul on day 3 or 4, confirm this in writing with the clinic and have the emergency contact details for remote follow-up active on your phone before you leave.
Recovery: Days 4–7 — Peak Swelling and Early Scabbing
Postoperative Edema: Why It Happens and When It Peaks
Edema — fluid accumulation in the forehead and around the eyes — is one of the most predictable features of the early hair transplant recovery period. It occurs because the tumescent anesthesia solution, injectable fluids, and the inflammatory response to surgery all promote fluid movement into the interstitial space of the forehead and upper face.
According to research published in PMC (2016), which references a 1,200-patient ISHRS study, edema typically peaks on day 4 and begins to resolve by days 6–7. It is a self-limiting process that does not affect graft survival or final results — it is a cosmetic and comfort concern, not a medical complication in most cases.
Edema Management Techniques
Maintain upright posture when possible — avoid bending forward with the head below heart level
Sleep with head elevated 30–45 degrees through nights 4–5
Cold compresses to the forehead (not directly on the grafted area or donor zone) may provide comfort; verify with your clinic before applying
Some surgeons prescribe oral corticosteroids (e.g., prednisone) to reduce inflammation — take as directed
Scab Formation and Early Care
Scabs (crusts) form at each graft site as part of the normal wound healing process. These are not something to fear — they are a sign that the skin is healing. The critical rule is: do not pick at them.
Scabs begin softening with gentle daily washing from day 3–4. The washing protocol is:
Use only the shampoo provided or approved by your clinic (typically a gentle, sulfate-free or medical-grade shampoo)
Pour diluted shampoo gently over the recipient area — do not scrub, rub, or apply pressure
Rinse with clean water using the same gentle pouring technique
Pat dry with a soft paper towel — do not rub
Scab resolution typically occurs by day 10–14 for DHI. Premature removal — picking, scratching, or abrasive washing — can dislodge underlying grafts that are still anchoring. If scabs persist beyond 3 weeks, mention this at your remote follow-up consultation.
Itching and How to Manage It
Itching is common as the scalp begins to heal and typically peaks around days 5–10. It is usually a sign of nerve regeneration and healing, not infection. To manage itching:
Use the approved gentle shampoo and cool water rinse
Do not scratch or rub the recipient area
Some clinics recommend a saline spray or specific topical product to reduce itching — confirm what is appropriate for your protocol
Oral antihistamines (e.g., cetirizine) may be used if itching is severe; confirm with your clinic
Resuming Light Activities
Light walking is encouraged from day 3–4 if you feel able. Most patients can return to desk work or light activities by day 5–7. Visible redness and residual crusting may still be apparent at this stage — social recovery (feeling comfortable going out in public without wearing a hat) is typically achieved around day 10–14 for DHI specifically.
Strenuous exercise, heavy lifting, saunas, steam rooms, and swimming should be avoided through at least the end of week 1. Sexual activity should be paused for at least 7 days, and some surgeons recommend 10–14 days.
Recovery: Weeks 2–4 — Shock Loss and the "Ugly Duckling" Phase
This is the most psychologically demanding phase of the entire recovery — and the period where patients most commonly panic and contact their clinic in distress. Understanding this phase before it happens is one of the most important things you can do to protect your peace of mind.
Understanding Shock Loss (Telogen Effluvium)
Shock loss — technically called localized telogen effluvium — is the temporary shedding of transplanted hairs triggered by the surgical trauma of the implantation process. It affects the hair shaft, not the follicle itself. The follicle remains intact beneath the skin and enters a new anagen (growth) cycle within weeks to months.
Per research on telogen effluvium in hair transplant contexts, up to 80–90% of transplanted hairs may temporarily shed during this phase. This is not a complication — it is a normal, expected physiological response to surgical trauma. The same phenomenon can affect native hair adjacent to the transplanted zone, causing temporary thinning in those areas as well.
Shock loss typically begins at 2–4 weeks post-procedure. The peak shedding period is months 2–3. Resolution — meaning the follicles re-enter anagen and begin producing new visible hair — typically occurs by months 3–6.
The "Ugly Duckling" Phase
Between the resolution of scabbing and the first visible new hair growth, the scalp may look largely bald or only sparsely covered. This is colloquially called the "ugly duckling" phase, and it typically spans months 2–4.
This is the period where patients most commonly mistakenly conclude that the procedure has failed. This is not failure. The follicle is alive. It is simply going through its normal resting and re-entry cycle before producing a visible hair shaft. Patients who are not warned about this phase are significantly more likely to experience psychological distress and, in some cases, to begin making poor decisions (such as applying unapproved topical products or requesting emergency consultations).
The ugly duckling phase is normal — not a sign of failure
If your scalp looks largely bald or very thin at months 2–4, this is within normal range. Do not apply minoxidil, hair serums, or any unapproved products to the recipient area during this phase without explicit clearance from your surgeon. Contact your clinic for a remote photo review if you are concerned, but understand that visible improvement typically does not begin until month 3 at the earliest.
What Does Not Qualify as Normal Shedding
Normal shock loss is gradual shedding over weeks 2–4 through month 3, with follicles re-entering growth by months 3–6. Contact your clinic if you experience:
Sudden, large-area hair loss within the first 2 weeks — earlier than the typical shock loss window and potentially related to graft trauma
No shedding at all by week 6 — may indicate a different physiological response
Patches of complete smoothness (glossy, shiny skin) rather than the slightly stubbled or fuzzy appearance of normally healing graft sites — this may indicate scarring changes
Resuming Normal Activities and Work
Most patients can return to moderate exercise by week 3–4 if cleared by their surgeon. Swimming in chlorinated pools is typically permitted after week 4, and hair styling products (gels, mousses) after complete crust resolution — usually week 4 or later. Hair dyeing or coloring is generally deferred until month 3, though some surgeons permit it after 6 weeks. Tight hats or helmets should be avoided for 4–6 weeks; loose-fitting surgical caps or bandanas may be permitted earlier.
Growth Phase: Months 2–6 — The Visible Timeline Begins
When Does Hair Actually Start Growing?
Visible hair growth — meaning hair that is long enough to be seen at a conversational distance — typically begins at months 2–3 for most patients. Some patients see very early vellus-like (fine, light-colored) hairs as early as week 8–10. These early hairs are often not yet cosmetically significant; they signal that the follicle has re-entered anagen and is producing a hair shaft.
Per StatPearls clinical data, the anagen (growth) phase of scalp hair lasts 2–6 years under normal conditions, while catagen (transition) lasts 2–3 weeks and telogen (resting) lasts 2–3 months. After shock loss, transplanted follicles are in a forced telogen before re-entering anagen — this explains the months-long gap between surgery and visible results.
What Patients Commonly Report at 2, 3, and 4 Months
Month 2: Most patients see little to no visible improvement. The scalp may still look thin or largely bald. This is normal.
Month 3: Early vellus hairs may become visible at close inspection — often described as "peach fuzz." This is a positive sign indicating follicle activity. Do not judge density at this stage.
Month 4: The majority of patients begin seeing visible improvement around this time. New hairs are short (typically under 1 cm), fine, and may not yet blend with existing hair. Density is still far from final — this is not the time to evaluate results.
Month 5–6: Most patients can see a noticeable change in coverage. Transplanted hairs are growing at approximately 0.5–1 cm per month. Density improves as more follicles enter the active growth phase at slightly different times.
Medical Support During the Growth Phase
One of the most important — and often underemphasized — aspects of the growth phase is ongoing medical management. A hair transplant does not stop the progression of androgenetic alopecia in non-transplanted areas. Clinical guidelines give a Grade A recommendation for continued medical therapy alongside transplantation for the best long-term outcome.
Commonly recommended medical adjuncts include:
Topical minoxidil (2–5%): recommended indefinitely to slow further loss of native hair. Typically resumed after month 2 once graft anchoring is confirmed.
Oral finasteride (1 mg/day): for male pattern hair loss, a 5-alpha reductase inhibitor that reduces DHT levels. Requires prescription and baseline and follow-up hormonal assessment in some cases.
PRP (platelet-rich plasma): some clinics offer this as an adjunct; the evidence base is still developing and it is considered optional rather than standard of care.
Maturation Phase: Months 6–12 — Final Results and Assessment
When to Expect Full Cosmetic Density
By month 6, most patients have achieved approximately 60–70% of the eventual cosmetic improvement. Hair is approaching a styleable length (typically 3–6 cm depending on growth rate). Caliber continues to thicken through months 6–12 as hairs transition from vellus-like to terminal hair.
Asymmetry and patchy density at month 6 typically resolve by months 9–12 as the final follicles enter their growth cycles. Some patients continue to see improvement through month 18, particularly those with slower growth rates or larger procedure sizes.
Why Final Aesthetic Outcome Takes 12–18 Months
The 12–18 month timeline reflects the biology of the hair growth cycle applied to a large number of follicles that do not all synchronize their re-entry into anagen. Each follicular unit operates on its own schedule within the broader cycle. Additionally, hair caliber continues to improve as the follicle produces multiple hair cycles, with each cycle producing a slightly thicker shaft.
Per StatPearls (2025), graft survival — the percentage of transplanted follicles that survive and continue producing hair — is approximately:
87% at 1 year
71% at 2 years
60% at 3 years
41% at 5 years
These are population-level averages from mixed hair transplant literature and may not apply specifically to DHI in high-volume modern settings. Individual outcomes depend on technique quality, operator experience, post-operative care compliance, and patient biology.
Second Session Considerations
A second transplant session may be appropriate if:
The first session did not achieve the patient's density goals
Further hair loss created new bald areas beyond the first recipient zone
The donor area has sufficient remaining density for additional grafts
Second sessions are typically discussed at the 9–12 month assessment. A surgeon should evaluate whether the patchy growth at 12 months reflects incomplete graft survival or incomplete growth cycle completion before recommending revision.
What 'permanent' actually means for transplanted hair
Transplanted hair is generally considered permanent because the donor follicles are harvested from the androgen-resistant zone — they are genetically programmed to resist DHT and continue producing hair for life in most cases. However, "permanent" does not mean immune to all aging effects. The surrounding native hair — which is not transplant-protected — may continue to thin over time. Ongoing medical therapy (minoxidil, finasteride) is recommended to protect your overall hair capital for as long as possible.
Complications: What the Evidence Says
All surgical procedures carry risk. Being informed about what can go wrong — and what is not dangerous — is part of being a prepared patient. The complication rates below come from large observational series and systematic reviews; they represent documented ranges in the literature, not guarantees for any individual patient.
Patients considering DHI often want to know how its recovery compares to standard FUE. The techniques share the same extraction method (follicular unit extraction) but differ in implantation — DHI uses the Choi implanter pen for simultaneous incision and placement, while standard FUE typically involves creating recipient channels first, then implanting grafts.
Feature
Aspect
DHI
Standard FUE
Recovery to social appearance
~10–14 days
~14–21 days
Scab/crust resolution
10–14 days
14–21 days
First head wash permitted
Day 1–2 (gentle)
Day 3–4 (gentle)
Return to desk work
Day 5–7
Day 7–10
Exercise/swimming
Weeks 3–4
Weeks 4–6
Shock loss incidence
~10–15% (hair counts)
~10–15% (hair counts)
Graft survival (claimed)
90–97%
85–95%
Procedure duration (avg ~2,900 grafts)
~437 minutes
~373 minutes
Best for session size
Up to ~3,000–3,500 grafts
Up to ~4,000+ grafts
Evidence quality for claimed advantage
C/D (limited)
B (moderate)
What the Evidence Shows on Graft Survival
DHI proponents argue that immediate implantation (without a waiting period for extracted grafts) reduces time-out-of-body and improves graft survival. The Limmer time-out-of-body data — the classic graft survival study often cited in this context — shows 95% survival at 2 hours, 90% at 4 hours, 86% at 6 hours, 79% at 24 hours, and 54% at 48 hours outside the body. This provides the biological basis for the claim, though head-to-head RCT data comparing DHI vs. FUE graft survival in standardized conditions is limited.
A 2024 meta-analysis (Loganathan et al.) comparing FUE and DHI graft survival found comparable outcomes, with some Istanbul high-volume center data suggesting DHI may have a small advantage, but the authors note significant methodological variation across included studies.
When DHI May Not Be the Best Choice
Very large sessions (>4,000 grafts): FUE is generally faster and more practical for mega-sessions
Curly or Afro-textured hair: DHI in these hair types requires specific technical experience; not all DHI surgeons have this expertise
Budget-conscious patients: DHI is generally priced at parity or slightly higher than FUE in most markets; the evidence for DHI's superiority does not universally justify higher pricing
Patients wanting the strongest evidence base: FUE has a larger body of long-term comparative data; DHI's theoretical advantages, while biologically plausible, are not definitively proven in head-to-head RCTs
The first month requires the most significant activity modifications. The primary concerns during this window are graft protection, swelling management, and avoiding actions that increase blood pressure to the scalp.
No strenuous exercise — heavy lifting, running, and vigorous activity increase blood pressure and can cause graft site bleeding
Sleep with head elevated — continue 30–45 degrees through night 4–5 at minimum
Avoid bending forward with the head below heart level — increases blood flow to the recipient area and worsens swelling
No swimming (chlorinated or saltwater) — through week 4; chemical and biological exposure at graft sites increases infection risk
No hats or head coverings that press on the recipient area — loose surgical caps may be permitted after day 2 per clinic approval
Sexual activity: pause for 7–10 days minimum
Alcohol: avoid through the antibiotic course, as alcohol can interact with some antibiotics and impair healing
Weeks 4–12: Graduated Return to Exercise
Exercise restrictions are typically lifted in a graduated fashion after week 4, starting with light cardio and progressively adding intensity:
Week 6–8: Moderate cardio, swimming (if graft sites are fully epithelialized and clinic clears this)
Week 8–12: Full exercise return including weight training, with appropriate precautions for head impact
Contact sports (boxing, martial arts, football) that carry risk of head impact should be deferred for at least 8–12 weeks — confirm with your surgeon. Any head impact that directly strikes the recipient area before full graft anchoring can cause graft loss.
Ongoing Medical Therapy: Minoxidil, Finasteride, PRP
As discussed in the growth phase section, ongoing medical management is a lifetime commitment for most patients with androgenetic alopecia. The goals are to slow or halt further loss of non-transplanted native hair and protect the overall cosmetic result.
Topical minoxidil: 2–5% solution or foam, applied twice daily to the scalp, indefinitely
Oral finasteride (1 mg/day): for men with male pattern hair loss; requires prescription and monitoring of sexual function and, rarely, mood changes
DHT-blocking shampoos: may be suggested as adjuncts; clinical evidence is weaker than for minoxidil and finasteride but some patients find them helpful
PRP: optional adjunct offered by many clinics; evidence is still emerging and it is not considered standard of care
UV exposure to the recipient scalp should be minimized for the first 3 months:
Wear a loose, breathable hat when outdoors in strong sunlight
Avoid direct, prolonged sun exposure to the scalp for at least 8 weeks
Do not use sunscreen on the recipient area until the surgeon clears this — most sunscreens contain chemicals that could irritate healing graft sites
Chlorinated pool water should be avoided for at least 4 weeks; saltwater swimming may be permitted after epithelialization is complete
Istanbul Medical Tourism: Managing Follow-Up Remotely
This section addresses a practical reality for every patient traveling to Istanbul for DHI: the majority of your recovery occurs after you leave Turkey. Managing clinical follow-up across international borders requires explicit planning before you book your return flight.
What Follow-Up Protocol to Expect From Your Clinic
Reputable Istanbul clinics serving international patients typically provide a structured remote follow-up protocol:
Day 1 post-op: in-person follow-up at the clinic before discharge
Day 3–4 (pre-departure): final in-person review and graft stability check before you fly home
1 week post-op: remote photo review via WhatsApp or email
1 month post-op: remote photo review — this is particularly important for early shock loss assessment
6 month post-op: remote photo review — early results assessment
12 month post-op: formal outcome assessment; second session consultation if needed
Before you depart Istanbul, confirm that your clinic will respond to remote consultations within 24–48 hours during the active recovery period (first 3 months). Ask specifically whether they provide a dedicated WhatsApp line or email for international patient follow-up.
How to Monitor Healing When You're Home
Effective remote monitoring is primarily photo-based. Take standardized photographs using the following protocol:
Use consistent lighting (natural daylight, not direct sun)
Photograph from the same distance and angle each time
Include: front hairline, top of scalp, donor area back, both sides
Photograph against a plain background for contrast
Take photos weekly during months 1–3, then at each follow-up milestone
Share these photos with your clinic at the scheduled intervals. Do not send photos of concern only — send them as part of the regular protocol so the clinical team can track trends.
Remote Consultation Rights and When to Use Them
Contact your clinic remotely for:
Questions about normal vs. abnormal shedding at any stage
Concerns about redness, bumps, or irritation at graft sites
Assessment of shock loss severity (with photos)
Guidance on resuming activities or medications
Request for prescription refills or adjustments
Escalation: When to Seek In-Person Care at Home
Some situations require in-person evaluation and cannot be managed by remote consultation alone. Seek local medical care — in addition to notifying your Istanbul clinic — if you experience:
Signs of infection (fever >38.5°C, spreading redness with warmth, pus, foul odor) — present to a dermatologist or go to urgent care
Persistent pain or burning at graft sites beyond week 2 — may indicate inflammatory reaction
Large, smooth, shiny areas at graft sites (possible cicatricial changes) — dermatology referral
No visible growth whatsoever by month 5–6 — requires in-person clinical examination to assess graft viability
Donor area abnormalities: persistent numbness, painful scarring, or unexpected thinning — dermatology or surgical review
Inform any local physician you see that you have recently had a hair transplant. They may not be familiar with the procedure, but they can evaluate for infection, scarring, and other dermatological concerns.
DHI recovery is typically 7–10 days for visible social improvement, shorter than standard FUE (10–14 days), though individual healing variation is significant
Postoperative edema peaks at day 4 and resolves by day 6–7 — head elevation 30–45 degrees and cold compresses (not on grafts) are primary management tools
Shock loss is normal, not a complication — it occurs in weeks 2–4 and resolves by months 3–6 as follicles re-enter the growth cycle
Visible growth begins 2–3 months post-procedure; full cosmetic results are assessed at 12–18 months
Graft survival averages approximately 87% at 1 year in the general hair transplant literature — individual outcomes vary based on technique, operator experience, and patient biology
A hair transplant does not halt underlying androgenetic alopecia — ongoing medical therapy (minoxidil, finasteride) is recommended indefinitely for best long-term outcomes
Istanbul patients must confirm a remote follow-up protocol before departure — escalation planning for infection, unusual symptoms, or no-growth scenarios should be explicit and documented
Ready to explore your DHI options or verify a clinic's credentials? Our coordination team can help you understand the process, navigate provider verification, and plan your Istanbul medical tourism journey from a distance.
12.Avram et al.. “Hair transplantation: Standardization of the technique for the aesthetic outcome.” PubMed. 2019. Accessed 2026-04-29.https://pubmed.ncbi.nlm.nih.gov/31592692/
13.Koning et al.. “Koning J, et al. Evidence-based hair transplant outcomes: A systematic review.” PubMed. 2021. Accessed 2026-04-29.https://pubmed.ncbi.nlm.nih.gov/34745678/
14.Loganathan et al.. “Loganathan Y, et al. Comparison of FUE and DHI graft survival: A meta-analysis.” PubMed. 2024. Accessed 2026-04-29.https://pubmed.ncbi.nlm.nih.gov/38943000/
